On July 27, 2026, Cameco Corp (NYSE: CCJ) saw its stock price rise by 0.7% following UBS’s upgrade from Neutral to Buy, with a price target set at C$166. This development comes amid a recent 18% decline in the stock price over the past month, which UBS attributes to market sentiment rather than fundamental weaknesses.
- GF Value™ verdict: Current price of $88.22 is 31.9% above the GF Value™ intrinsic estimate of $66.87, indicating the stock is significantly overvalued.
- GF Score™: A strong 85/100, reflecting robust overall quality despite valuation concerns.
- Key financial signal: Nine gurus currently hold CCJ, with seven trimming and four adding positions recently, highlighting mixed but active institutional interest.
What's Behind the News?
The recent upgrade by UBS to a Buy rating on Cameco’s stock reflects growing optimism about the nuclear energy sector’s long-term prospects. UBS analysts pointed out that long-term uranium contract prices are at record highs, supported by increasing utility contracting and government backing for nuclear power. They forecast that nuclear demand will exceed a 3.5% annual growth rate, signaling a potential growth phase for the sector. This outlook contrasts with the recent 18% price decline over the past month, which UBS attributes primarily to negative market sentiment rather than any deterioration in Cameco’s fundamentals.
Cameco Corp is a leading uranium producer and supplier, operating in the Energy sector under the "Other Energy Sources" industry classification. The company’s business spans uranium mining, refining, conversion, and nuclear fuel fabrication, with its Westinghouse segment providing products and services to nuclear reactors worldwide. With a market capitalization of $38.46 billion, Cameco is a significant player in the clean energy space, supplying uranium that fuels reliable baseload electricity generation globally.
Is CCJ Overvalued or Undervalued?
According to GuruFocus’ proprietary GF Value™ metric, Cameco’s intrinsic value stands at $66.87 per share, while the current market price is $88.22. This implies the stock is trading approximately 31.9% above its estimated fair value, suggesting a substantial margin of overvaluation. Investors looking for a margin of safety may find this premium concerning, especially given the stock’s elevated valuation multiples.
Supporting this valuation caution, Cameco’s trailing twelve months (TTM) price-to-earnings (P/E) ratio is 81.24x, which, although high, remains below its five-year median P/E of 110.84x. This indicates that while the stock is expensive relative to current earnings, it is somewhat cheaper than its historical peak valuations. The forward P/E ratio is not available, which limits forward-looking valuation insights. For more on GF Value™, visit GF Value™.
What Does CCJ's GF Score™ Tell Us?
The GF Score™ aggregates multiple dimensions of a company’s financial health, profitability, growth, valuation, and momentum into a single score that helps investors quickly gauge overall quality. Cameco’s GF Score™ of 85/100 is a strong indicator of the company’s solid fundamentals and operational strength. The score reflects particularly high marks in financial strength and growth, while valuation remains a relative weakness.
| Metric | Rating |
|---|---|
| GF Score™ | 85/100 |
| Financial Strength | 8/10 |
| Profitability | 6/10 |
| Growth | 9/10 |
| Valuation | 5/10 |
| Momentum | 8/10 |
Cameco’s strong financial strength score (8/10) is supported by a robust Altman Z-Score of 12, indicating low bankruptcy risk, and a Piotroski F-Score of 8, signaling healthy financial conditions. Growth ranks highly at 9/10, reflecting impressive earnings and revenue growth over recent years. However, valuation ranks only 5/10, consistent with the GF Value™ assessment of overvaluation. Momentum is also strong at 8/10, suggesting positive price trends despite recent volatility. For further details, visit CCJ stock page.
What Are Gurus and Insiders Doing with CCJ?
GuruFocus tracks 9 premium gurus holding Cameco shares, with 7 of these investors trimming their positions and 4 adding to theirs in recent quarters. This mixed activity indicates a cautious but engaged institutional investor base, reflecting differing views on valuation and growth prospects. Insider activity is minimal, with no reported insider purchases or sales in the past three months, suggesting insiders are neither aggressively buying nor selling at current levels.
What This Means for Investors
While Cameco’s GF Score™ of 85/100 highlights a fundamentally strong company with solid growth and financial health, the GF Value™ analysis signals that the stock is currently trading significantly above its intrinsic value by nearly 32%. This overvaluation, combined with a high P/E ratio relative to earnings, suggests limited margin of safety for new investors at current prices. The mixed guru ownership activity further underscores a nuanced market view. Investors should weigh these valuation concerns carefully against the company’s long-term growth potential and sector tailwinds. For a deeper dive into Cameco’s fundamentals and valuation, visit the CCJ stock page or explore opportunities using the GuruFocus Stock Screener.
Frequently Asked Questions
What is CCJ's GF Score™?
CCJ’s GF Score™ is 85 out of 100, indicating strong overall financial health, solid growth, and good momentum, though valuation remains a relative weakness.
Is CCJ overvalued or undervalued?
Based on GF Value™, CCJ is approximately 31.9% overvalued, trading at $88.22 compared to an intrinsic value estimate of $66.87.
What is CCJ's P/E ratio compared to historical?
CCJ’s trailing twelve months P/E ratio is 81.24x, which is below its five-year median P/E of 110.84x, indicating it is trading cheaper than its historical peak valuations but still at a high multiple.
This stock alert was generated using automated technology and GuruFocus financial data to provide readers with timely and accurate market reporting. This content was reviewed by GuruFocus editorial team prior to publication. Please send any questions or comments about this story to [email protected].
